Bill

Bill > H1703


MA H1703

Relative to opioid drug manufacturer assessments


summary

Introduced
01/22/2019
In Committee
01/22/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

Relative to opioid drug manufacturer assessments. Mental Health, Substance Use and Recovery.

AI Summary

This bill establishes a new assessment on opioid drug manufacturers in Massachusetts. The assessment would be based on the ratio of each manufacturer's annual distribution and dispensing of opioid drugs in the state compared to the total statewide distribution and dispensing. The total annual assessment would not exceed $15 million, and the funds would go to the Opioid Treatment and Addiction Prevention Fund to support prevention, treatment, management, and research related to opioid addiction and alternative pain management. The Department of Public Health is required to promulgate regulations to implement the assessment within 180 days, and the assessment will take effect on June 30, 2020.

Committee Categories

Health and Social Services

Sponsors (22)

Last Action

Accompanied a new draft, see H4532 (on 03/09/2020)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...